JP2023553610A5 - - Google Patents

Info

Publication number
JP2023553610A5
JP2023553610A5 JP2023534695A JP2023534695A JP2023553610A5 JP 2023553610 A5 JP2023553610 A5 JP 2023553610A5 JP 2023534695 A JP2023534695 A JP 2023534695A JP 2023534695 A JP2023534695 A JP 2023534695A JP 2023553610 A5 JP2023553610 A5 JP 2023553610A5
Authority
JP
Japan
Prior art keywords
sequence
pharmaceutical composition
composition according
seq
sirna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023534695A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023553610A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2021/135476 external-priority patent/WO2022117085A1/en
Publication of JP2023553610A publication Critical patent/JP2023553610A/ja
Publication of JP2023553610A5 publication Critical patent/JP2023553610A5/ja
Pending legal-status Critical Current

Links

JP2023534695A 2020-12-03 2021-12-03 重症急性呼吸器症候群関連コロナウイルスを標的とする干渉ｒｎａｓ、及びｃｏｖｉｄ－１９を治療するためのそれらの使用 Pending JP2023553610A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CNPCT/CN2020/133565 2020-12-03
CN2020133565 2020-12-03
CNPCT/CN2021/121762 2021-09-29
CN2021121762 2021-09-29
PCT/CN2021/135476 WO2022117085A1 (en) 2020-12-03 2021-12-03 Interfering rnas targeting severe acute respiratory syndrome-associated coronavirus and uses thereof for treating covid-19

Publications (2)

Publication Number Publication Date
JP2023553610A JP2023553610A (ja) 2023-12-25
JP2023553610A5 true JP2023553610A5 (https=) 2024-12-11

Family

ID=81853844

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023534695A Pending JP2023553610A (ja) 2020-12-03 2021-12-03 重症急性呼吸器症候群関連コロナウイルスを標的とする干渉ｒｎａｓ、及びｃｏｖｉｄ－１９を治療するためのそれらの使用

Country Status (8)

Country Link
US (1) US20240026362A1 (https=)
EP (1) EP4256055A4 (https=)
JP (1) JP2023553610A (https=)
KR (1) KR20230142701A (https=)
CN (1) CN116964202A (https=)
AU (1) AU2021390130A1 (https=)
IL (1) IL303367A (https=)
WO (1) WO2022117085A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117919267B (zh) * 2024-01-24 2024-12-03 石河子大学 miR2911在制备抗猪繁殖与呼吸障碍综合症病毒的药物中的应用
CN118001297B (zh) * 2024-02-01 2025-01-28 中国人民解放军军事科学院军事医学研究院 一种治疗SARS-CoV-2及其变体感染的多功能组合物及其制备方法
CN118853668A (zh) * 2024-06-24 2024-10-29 中山大学 一种靶向SARS-CoV-2的siRNA自组装纳米颗粒及其制备方法与应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE443765T1 (de) * 2003-03-21 2009-10-15 Santaris Pharma As Analoga kurzer interferierender rna (sirna)
CN1590545A (zh) * 2003-06-04 2005-03-09 杭州新瑞佳生物医药技术开发有限公司 攻击SARS病毒mRNA分子的小干扰核糖核酸分子（SiRNA）及应用
CN101113158A (zh) * 2006-12-18 2008-01-30 四川大学 干扰SARS病毒RdRp基因功能的siRNA
US10822379B1 (en) * 2020-03-12 2020-11-03 University of Pittsburgh—of the Commonwealth System of Higher Education Molecules that bind to SARS-CoV-2
WO2021183887A1 (en) * 2020-03-13 2021-09-16 The Board Of Trustees Of The Leland Stanford Junior University Systems and methods for viral genome targeting
TW202204615A (zh) * 2020-03-26 2022-02-01 美商阿尼拉製藥公司 冠狀病毒ｉＲＮＡ組成物及其使用方法
CN111778253B (zh) * 2020-04-03 2022-02-18 苏州吉玛基因股份有限公司 一种小干扰核酸及组合物和应用
CN111748557B (zh) * 2020-04-03 2022-03-11 苏州吉玛基因股份有限公司 抑制新型冠状病毒的小干扰核酸及组合物和应用
AU2021251249A1 (en) * 2020-04-10 2022-11-10 Aligos Therapeutics, Inc. Short interfering nucleic acid (siNA) molecules and uses thereof for coronavirus diseases
CN111518809A (zh) * 2020-05-12 2020-08-11 杭州勇诚睿生物科技有限公司 干扰新冠病毒COVID-19基因表达的siRNA及其应用
RU2733361C1 (ru) * 2020-07-14 2020-10-01 Федеральное государственное бюджетное учреждение "Государственный научный центр "Институт иммунологии" Федерального медико-биологического агентства России (ФГБУ "ГНЦ Институт иммунологии" ФМБА России) Средство для ингибирования репликации вируса SARS-CoV-2, опосредованного РНК-интерференцией
EP4359528A1 (en) * 2021-06-25 2024-05-01 Alpine Antiviral GmbH Sirna combinations targeting sars-cov-2 and/or host factor transcripts

Similar Documents

Publication Publication Date Title
CN108136206B (zh) 抗乙型肝炎病毒的组合物和药剂及其用途
JP4718379B2 (ja) 修飾された低分子干渉ｒｎａ分子および使用方法
JP2023553610A5 (https=)
RU2733361C1 (ru) Средство для ингибирования репликации вируса SARS-CoV-2, опосредованного РНК-интерференцией
EP4174177A1 (en) Coronavirus-specific double-stranded oligonucleotides, and composition comprising same for preventing and treating coronavirus disease-19
JP2022511550A5 (https=)
JP2012255024A (ja) 改変型の小さい干渉ｒｎａ分子および使用方法
CN101970662A (zh) 带有修饰碱基的寡核苷酸作为抗病毒剂的应用
CA2436519A1 (en) Selection of catalytic nucleic acids targeted to infectious agents
JPH09501047A (ja) アンチセンスオリゴヌクレオチドおよびヒト免疫不全ウイルス感染におけるその使用
US20240102015A1 (en) Antisense Oligonucleotides Targeting SARS-CoV-2
RU2014121304A (ru) Ингибирование экспрессии вирусных генов
JP2025500860A5 (https=)
JP2024512635A5 (https=)
WO2018058006A1 (en) Oligonucleotides containing 2'-deoxy-2'fluoro-beta-d-arabinose nucleic acid (2'-fana) for treatment and diagnosis of retroviral diseases
JP4545091B2 (ja) Ｃ型肝炎ウイルスの働きを阻害するオリゴリボヌクレオチドまたはペプチド核酸
US20160281089A1 (en) Prevention of viral infectivity
EP2325314A2 (en) Targeting opposite strand replication intermediates of single-stranded viruses by RNAI
Kwok et al. Inhibition of influenza A virus replication by short double-stranded oligodeoxynucleotides
EP2031059A1 (en) siDNA against hepatites C virus (HCV)
CN112375758A (zh) 一类新型抗汉坦病毒反义核酸序列及其应用
Shi et al. [Retracted] Influenza A Virus Production in Mouse Lung Is Inhibited by Inhalation of Aerosol Polyethylenimine/Short Hairpin RNA Plasmid Complexes
Roshan Mehr et al. Recent Developments in RNA Therapeutics for Humans Disorders
Li et al. Engineered pistol ribozymes selectively target KRAS G12V with enhanced efficacy by capping modification
TW202603166A (zh) 黏蛋白５Ｂ（ＭＵＣ５Ｂ）靶向ｓｉＲＮＡ及反義寡核苷酸及其使用方法